Overview
No overview information available.
Background
No background information available.
Indication
⑴本品主要用于治疗铅中毒，亦可用于治疗鎘、锰、铬、镍、钴和铜中毒，以及作诊断用的铅移动试验。 ⑵亦可作为药用附加剂用作抗氧增效剂、稳定剂及水软化剂等。 ⑶用于眼科治疗眼部石灰烧伤、带状角膜变性、角膜血染、眼铁质沉着症及眼铜质沉着症。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Calcium Disodium Edetate Tablets | 国药准字H11021931 | 化学药品 | 片剂 | 11/27/2020 | |
| Calcium Disodium Edetate Injection | 国药准字H12020890 | 化学药品 | 注射剂 | 7/27/2020 | |
| Calcium Disodium Edetate Injection | 国药准字H11022372 | 化学药品 | 注射剂（小容量注射剂） | 8/11/2021 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||